The intrinsic cardiac plexus represents a major peripheral integration site for neuronal, hormonal, and locally-produced neuromodulators controlling efferent neuronal output to the heart. This study examined the interdependence of norepinephrine, muscarinic agonists, and angiotensin II (Ang II), to modulate intrinsic cardiac neuronal activity. Intracellular voltage recordings from whole mount preparations of the guinea pig cardiac plexus were used to determine changes in active and passive electrical properties of individual intrinsic cardiac neurons. Application of either adrenergic or muscarinic agonists induced changes in neuronal resting membrane potentials, decreased afterhyperpolarization duration of single action potentials and increased neuronal excitability. Adrenergic responses were inhibited by removal of extracellular calcium ions, while muscarinic responses were inhibited by application of TEA.
Introduction
Control of cardiac function is determined, in part, by the precise coordination of outputs from the sympathetic and parasympathetic branches of the autonomic nervous system. The specific efferent output from each branch is in turn controlled by integration of multiple inputs.
In addition to inputs from preganglionic neurons, evidence indicates that sensory fibers and local circuit neurons (interneurons) modulate peripheral reflex processing (4; 6; 33). These peripheral autonomic ganglia can function interdependently with central components of the cardiac nervous system for precise beat-to-beat control of cardiac electrical and mechanical functions (4; 6). The intrinsic cardiac plexus, located within the cardiac tissue itself, exemplifies fundamental aspects of this coordinated communication.
The peripheral components of the cardiac nervous system, including the intrinsic cardiac ganglia, express a complex neurochemical profile (19; 33) . Previous studies have shown that intracardiac neurons possess receptors for a variety of putative neuromodulators, including muscarinic receptors (7; 24; 38) , adrenergic receptors (22; 33), neuropeptides (11; 17) , and locally produced chemicals (34). Studies on the direct interactions between the sympathetic and parasympathetic neurons in this plexus are few (26), although the importance of this balance is integral to the normal function of the organism. For example, surgical disruption of the right atrial ganglionated plexus in dogs prevents parasympathetic-mediated bradycardia while maintaining parasympathetic-induced suppression of sympathetic inputs modulating chronotropic function (30; 35). This residual response is attributed to sympathetic/parasympathetic neural interactions mediated within the cardiac plexus (30).
Consequently, in the present study, our first objective was to examine the potential for intraganglionic interactions between sympathetic and parasympathetic efferent neurons by determining the effects of both muscarinic and adrenergic neuromodulation on the output of intracardiac neurons. This included characterization of the potential contributions of α and β adrenoreceptor subtypes to passive and active membrane properties of intrinsic cardiac neurons.
Previous studies have also demonstrated that neurohumoral interactions can impact functional cardiac control and that these responses are altered with chronic cardiac stress (6) .
For example, angiotensin II (Ang II) modulates peripheral autonomic neuronal function (15; 20) .
Ang II/autonomic interactions remodel with the progression of cardiac disease (2; 13) and, thus, represent novel targets to mitigate adverse disease progression in both cardiac tissues and within the associated cardiac nervous system (37) . Stress-induced changes in cardiac tissues and associated neurohumoral regulators can be either detrimental or beneficial. For example, with renin-angiotensin system activation, increased AT 1 receptor activity is associated with increased risk of sudden cardiac death (14; 21) , while increases in AT 2 receptor activation is considered cardioprotective (9; 25; 28) . While Ang II is recognized as a putative neuromodulator of peripheral autonomic function, the potential effects of AT 1 and AT 2 receptors on active and passive membrane properties of efferent neurons of the intrinsic cardiac neurons have not been well characterized. In addition, the potential interactions between Ang II and adrenergic receptor systems on intrinsic cardiac neurons have not been considered either, even though both are coactivated during the progression of cardiac disease (6; 13; 30; 36). The potential for Ang II/adrenergic interactions to modulate intracardiac neurons underlie the second objective for the current studies. The data presented here demonstrate that Ang II potentiates both adrenergic and muscarinic-mediated activation of intrinsic cardiac neurons, primarily via AT 2 receptor dependent mechanisms.
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Material and Methods
Animals:
Hartley guinea pigs (male, 800-1000g, Charles River), were euthanized by CO 2 inhalation and exsanguination. All procedures were approved by the Institutional Animal Care and Use Committees of Ithaca College and were in accordance with the American Physiological Society Guiding principles for research involving animals and human beings (1).
The heart was removed and placed into ice-cold Krebs Ringer solution (mM: NaCl 121, KCl 5.9, CaCl 2 2.5, MgCl 2 1.2, NaH 2 PO 4 1.2, NaHCO 3 25, glucose 8, aerated with 95% O 2 / 5% CO 2 for a pH of 7.4). The cardiac plexus, located in the epicardium of the atria, was dissected as previously described (17; 29) . The region studied is located primarily in the wall of the left atrium underlying the area of the coronary sinus and was exposed by opening the atria and removing the overlying muscle and connective tissue. The isolated plexus was pinned to a Sylgard-lined 60 mm Petri dish and continuously superfused (6-8 mL/min) with 35-37°C Krebs Ringer. Norepinephrine (10 -3 M), bethanechol (10 -3 M), and histamine (10 -3 M) were applied by local pressure ejection (6-9 psi, Picospritzer, General Valve Corp) through small tip diameter (5-10 μm) glass micropipettes positioned 50-100 μm from individual neurons. Up to two different drugs could be tested simultaneously by local pressure ejection. For multiple tests of responses in the same cell, the cells were washed with the circulating Krebs solution for several minutes between drug applications. Cells were tested to insure that all responses had returned to control levels prior to additional testing. Angiotensin II (100 nM) and the AT 2 agonist CGP-42112A (Sigma, 100 nM) were applied via the circulating bath solution. Adrenergic agonists phenylephrine (α 1 selective), clonidine (α 2 selective), dobutamine (β 1 selective), and terbutaline (β 2 selective) were applied by either local pressure ejection (10 -3 M) or by bath perfusion (10 6 µM). Angiotensin receptor inhibitors telmasartin ( AT 1 selective, Sigma, 1 µM) and PD 123319 (AT 2 selective, Tocris Bioscience, 1 µM,) were applied by bath perfusion.
Electrophysiological Methods: Intracellular voltage recordings from intracardiac neurons were obtained using an AxoClamp 2B amplifier (Axon Instruments) from cells impaled with 2M
KCl-filled microelectrodes . Data was collected, digitized, and analyzed using pClamp 8.2 (Axon Instruments). Individual neurons were used for an experiment if the membrane potential was more negative than -40 mV and action potentials had an overshoot of at least 20 mV.
Single action potentials were evoked by depolarizing current injection (0.5-0.8 nA, 5 msec), averaged (5-6 individual recordings) and analyzed to determine the amplitude and duration (as determined by a return to the resting membrane potential) of the afterhyperpolarizing potential (AHP). Neuronal excitability was monitored by observing the response to a series of long depolarizing current pulses (0.1-0.6 nA, 500 msec). The number of evoked action potentials (AP) versus stimulus intensity was determined to assess changes in excitability.
Following characterization of the basic electrophysiological properties, induced changes in evoked AP frequency for each cell were assessed immediately following 1-2 sec application of either norepinephrine (NE) or the muscarinic agonist bethanechol. Each was applied by local pressure ejection immediately adjacent (~50-100 μm) to the recorded neuron, and doses were chosen that produce maximal or near maximal responses. Changes in action potential frequency versus stimulus intensity were determined to assess relative drug-induced changes in excitability of intrinsic cardiac neurons. Angiotensin II or specific angiotensin receptor agonists were added to the circulating bath solution and neuronal responses to NE, bethanechol, or histamine (applied 7 by local pressure ejection) were assessed during the superfusion. The bath solution was then switched back to the normal Krebs solution for a total Ang II application time of 2-4 min.
Adrenergic agonists were applied either by local pressure ejection or by inclusion in the circulating bath solution. Individual action potentials and neuronal excitability were assessed in the presence and absence of the agonists for either application method.
Inhibition of different ion channels was achieved through addition of known inhibitors to the bath solution, or omission of specific ions. Tetraethylammonium (TEA, 5 mM) and BaCl 2 (1 mM) were added to inhibit potassium channels. CsCl (2 mM) was added to inhibit the hyperpolarization-activated current, I h . 4-aminopyridine (1 mM) was added to inhibit the Acurrent (I A ). Calcium was removed from the Krebs solution, with MgCl 2 increased to 4 mM, to prevent influx of extracellular calcium. Solutions were superfused over the tissue and the neuronal responses to NE and bethanechol were measured before, during, and after application.
Statistical Analysis:
Values are expressed as the mean + standard error. Statistical significance was determined by Students t-test or ANOVA, with a p value less than 0.05 considered significant. Post hoc analysis was performed using Dunn's method. Best fit lines for the frequency curves were generated using either a linear or single exponential relationship, which provided estimates of the R 2 values of 0.98 or greater.
Results
Adrenergic and muscarinic responses
Whole mount preparations of the guinea pig cardiac plexus were used to monitor individual neuronal responses to locally-applied norepinephrine (NE, 10 Single action potentials were produced by injection of a depolarizing current pulse (0.5 -0.8 nA, 5 msec) and averaged. Analysis of the afterhyperpolarization (AHP) phase of the action potential showed a decrease in AHP duration following application of either NE or bethanechol ( Figure 1B ). Prior to application, the average AHP amplitude was 15.8 ± 0.4 mV (n=37) with a duration of 260 ± 11 msec. Following NE application (n=14), the AHP amplitude was 15.6 ± 0.9 mV (not significantly different from control) with a duration of 196 ± 9 msec (p < 0.001 by ttest). Similarly, following bethanechol application (n=9), the AHP amplitude was 15.5 ± 1.0 mV (not significantly different) with a duration of 180 ± 12 msec (p < 0.001 by t-test).
Neuronal excitability was assessed by monitoring the number of action potentials produced by a series of depolarizing current steps (0.1-0.6 nA, 500 msec). As shown in Figure   1C (top panel), the majority of neurons fired only one or two action potentials at the onset of the 9 depolarizing stimulus. However, following either NE or bethanechol application, the same current pulse produced a significant increase in the number of evoked APs. In addition, bethanechol application consistently resulted in a greater increase in neuronal firing than NE ( Figure 2 ).
Ionic mechanisms underlying adrenergic and muscarinic responses
Several potential ionic mechanisms could underlie the observed responses to NE and bethanechol. Previous studies of NE effects on intracardiac neurons of rats have demonstrated that NE can alter calcium currents (41), while other studies showed that NE can activate a nonspecific cation channel (22) . Several muscarinic receptor-mediated changes in ion currents have been described for intracardiac neurons, including inhibition of the m-current (32), regulation of the delayed rectifier potassium current (3), inhibition of calcium currents (12) , and stimulation of intracellular calcium release (7) . To examine whether any of these might contribute to the effects observed in these cells, a variety of inhibitors of different ion channels were added to the circulating Krebs solution. The ability of NE and bethanechol to increase neuronal firing in the presence or absence of these different inhibitors was then assessed. Barium (1 mM) was added to inhibit inwardly rectifying potassium currents, including the m-current (16; 18) . Barium alone produced an increase in basal excitability levels. However, both NE and bethanechol were still able to further increase neuronal firing in the presence of 1 mM Ba 
Characterization of adrenergic receptors
Specific adrenergic agonists were used to evaluate the receptor subtypes responsible for the observed NE responses. Agonists were applied either by local pressure ejection (10 Table 1 indicates the observed resting membrane potential response with agonist application for each of the responders and shows a heterogeneous expression of adrenergic receptors within the cardiac plexus. There was no apparent correlation between the detection of a membrane response, or the direction of the change, and the ability to increase evoked action potentials. Application of α-adrenergic agonists 11 produced the greatest percentage of responsive neurons (41% for α 1 and 38% for α 2 ) with β-adrenergic agonist application producing fewer responsive neurons (20% for β 1 and 17% for β 2 ).
A total of 31 cells were challenged with at least two different agonists. Of those, 7 showed responses to 2 different agonists. In each case, the cells responded to the α 1 agonist and either β 2 (3 cells), β 1 (2 cells) or α 2 (2 cells).
Angiotensin II modulation of responses
Cardiac ganglion preparations were superfused with Ang II to determine its potential to directly modulate intracardiac neuronal activity. Ang II was applied via addition to the circulating bath solution (100 nM) and was allowed to circulate for several minutes. Single action potentials, neuronal excitability, and responses to NE and bethanechol were assessed in the presence and absence of Ang II. In addition, another known endogenous modulator of intracardiac neuron function, histamine (34), was also examined to determine if any effects of Ang II on neuronal activity were specific or relatively nonspecific to different potential neuromodulators. Ang II did not alter resting membrane potential or single action potential characteristics (data not shown). The number of evoked action potentials with increased depolarizing current pulses showed a small, but significant increase with Ang II at the highest stimulus intensity only ( Figures 4B and 5 ). In the presence of Ang II, application of either NE or bethanechol produced a significantly greater number of action potentials in response to the same stimulus compared to control conditions (Figures 4 and 5) . This response was readily reversible upon removal of Ang II, with excitability responses returning to levels observed prior to Ang II application. In contrast, Ang II did not alter the neuronal response to histamine. Comparison of the effects of Ang II at maximal stimulations for control, NE, bethanechol, and histamine shows a significant increase in evoked action potentials in control, NE and bethanechol, but not with histamine ( Figure 5 
Discussion
Integration of information between the sympathetic and parasympathetic nervous system is crucial in the maintenance of cardiac function. The experiments presented here demonstrate that adrenergic neurotransmitters can increase output from intrinsic cardiac neurons via multiple adrenergic receptor subtypes, α-adrenergic being the predominant type. In addition, local 13 stimulation with angiotensin II can also modulate intracardiac neuronal function, as well as enhance the increase in excitability induced by both adrenergic and muscarinic agonists. Thus, an increase in sympathetic activity and Ang II production can lead to a concomitant increase in intracardiac neuronal output to the heart. This may represent a feedback loop for parasympathetic blunting of sympathetic responses, or an integration of autonomic outputs within the intrinsic ganglion to modify overall cardiac function. . This suggests that mechanisms other than inhibition of Im contributed to the muscarinic regulation of neuronal excitability. We did find that the muscarinic response was inhibited by extracellular TEA, which would support either modulation of delayed rectifier channels or inhibition of calcium-activated potassium channels, both of which are TEA-sensitive (18) . In addition, a muscarinic-induced decrease in calcium currents could also lead to a decrease in calcium-activated potassium channels, which could result in the decrease in AHP duration seen with bethanechol application. 
Perspectives and Significance
Integration of sympathetic and parasympathetic efferent neuronal outputs to the heart can occur at the level of the postganglionic neurons (30; 35). The studies presented here show that intracardiac neurons of the guinea pig cardiac plexus can be modulated by both adrenergic signals and hormonal signals, such as angiotensin II. Both of these neuromodulators can produce an increase in neuronal output, and the combination of NE and Ang II actually produces an even higher evoked output from these neurons.
Given that chronic heart disease can result in increased sympathetic activity as well as increases in circulating and locally produced Ang II levels (6; 8; 13), these results suggest that the parasympathetic nervous system may compensate for these pathologies, in part, by increasing parasympathetic output. In fact, increased parasympathetic efferent output is correlated with protection against cardiac arrhythmias and sudden cardiac death in the setting of ischemic heart disease (27; 39). Future studies will focus on the impact of these different modulators on the output of intrinsic cardiac neurons with stimulation of fiber inputs. If these modulators are indeed producing functional changes in neuronal excitability, then this should be evident in changes in neuronal firing with synaptic stimulation. Future studies are needed to expand upon 17 the neurochemical/neurohumoral alterations within the cardiac nervous system and the cardiac tissues they innervate during disease progression with the ultimate goal of developing strategies to mitigate such adverse remodeling and thereby help preserve overall cardiac function. The percentage of cells that showed an increase in evoked action potentials (APs) in the presence of the agonist is indicated and, for those cells that did induce an increase in excitability, the membrane response produced with agonist application is indicated. 
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